Literature DB >> 15933861

To: Mackin P, Watkinson HM, Young AH (2005) Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study. Diabetologia 48:215-221.

J Engl, M Laimer, W W Fleischhacker, C F Ebenbichler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15933861     DOI： 10.1007/s00125-005-1788-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  10 in total

1.  Association of olanzapine-induced weight gain with an increase in body fat.

Authors:  U Eder; B Mangweth; C Ebenbichler; E Weiss; A Hofer; M Hummer; G Kemmler; M Lechleitner; W W Fleischhacker
Journal:  Am J Psychiatry       Date:  2001-10       Impact factor: 18.112

Review 2.  Antipsychotic-induced weight gain: a review of the literature.

Authors:  D B Allison; D E Casey
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

Review 3.  Consensus development conference on antipsychotic drugs and obesity and diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

4.  Olanzapine-induced hyperglycemia: role of humoral insulin resistance-inducing factors.

Authors:  Markus Laimer; Christoph F Ebenbichler; Michael Kranebitter; Ursula Eder; Barbara Mangweth; Elisabeth Weiss; Alex Hofer; Martina Hummer; Georg Kemmler; Monika Lechleitner; Josef R Patsch; W Wolfgang Fleischhacker
Journal:  J Clin Psychopharmacol       Date:  2005-04       Impact factor: 3.153

5.  The effect of clozapine on blood glucose metabolism.

Authors:  Beang-Jin Chae; Byung-Jo Kang
Journal:  Hum Psychopharmacol       Date:  2001-04       Impact factor: 1.672

6.  Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study.

Authors:  P Mackin; H M Watkinson; A H Young
Journal:  Diabetologia       Date:  2005-02-02       Impact factor: 10.122

7.  Olanzapine induces insulin resistance: results from a prospective study.

Authors:  Christoph F Ebenbichler; Markus Laimer; Ursula Eder; Barbara Mangweth; Elisabeth Weiss; Alex Hofer; Martina Hummer; Georg Kemmler; Monika Lechleitner; Josef R Patsch; W Wolfgang Fleischhacker
Journal:  J Clin Psychiatry       Date:  2003-12       Impact factor: 4.384

8.  Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.

Authors:  Jean-Pierre Lindenmayer; Pal Czobor; Jan Volavka; Leslie Citrome; Brian Sheitman; Joseph P McEvoy; Thomas B Cooper; Miranda Chakos; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112

9.  The soluble leptin receptor in olanzapine-induced weight gain: results from a prospective study.

Authors:  Christoph Ebenbichler; Markus Laimer; Michael Kranebitter; Monika Lechleitner; Josef R Patsch; Susanne Baumgartner; Monika Edlinger; Alex Hofer; Martina Hummer; Maria A Rettenbacher; W Wolfgang Fleischhacker
Journal:  Schizophr Res       Date:  2005-06-01       Impact factor: 4.939

10.  A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance.

Authors:  Oliver D Howes; Ajay Bhatnagar; Fiona P Gaughran; Stephanie A Amiel; Robin M Murray; Lyn S Pilowsky
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.